Adial Pharmaceuticals Inc.
13F holders, Q4 2024 (December 31)1holders
$1.01avg. 13F price*
At the end of Q4 2024, 1 institutions reported holding Adial Pharmaceuticals Inc. in their 13F filings. The largest holder was 1620 Investment Advisors, Inc. ($4K).
- Company
- Adial Pharmaceuticals Inc.
- CUSIP
- 00688A106
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $4K |
| Exits | 0 | $0 |
Ownership 1 holders
| 1620 Investment Advisors, Inc. | 0.00% | New | 3,600 | $4K |
"% of holder's portfolio" is ADIAL PHARMACEUTICALS INC's weight in each manager's 13F, not the share of Adial Pharmaceuticals Inc. the manager owns.